Proteomics International Laboratories Ltd is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to delegates at the 17th Bioshares Biotech Summit on 25 July 2023. To.
Proteomics International Laboratories Ltd , a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business.
Proteomics International Laboratories Ltd has been invited to present the latest results from its novel blood test for oesophageal adenocarcinoma at the 19th ISDE World Congress for Esophageal.
Proteomics International Laboratories Ltd is pleased to announce that the National Association of Testing Authorities of Australia has approved the continuation of the Company s ISO 17025. | April 16, 2023